Regulation of chemoconvulsant-induced seizures by store-operated Orai1 channels

Kotaro Hori1, Shogo Tsujikawa1, Michaela M Novakovic1

  • 1Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Insights

Mice lacking the Orai1 calcium channel in the brain experienced more severe seizures. This is because Orai1 channels are crucial for the function of inhibitory neurons, which normally prevent excessive brain excitation.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Calcium Signaling

Background:

  • Temporal lobe epilepsy involves an imbalance between neural excitation and inhibition.
  • Altered calcium (Ca2+) signaling is implicated in epilepsy, but the roles of specific Ca2+ channels remain unclear.
  • Store-operated Orai1 channels are critical for Ca2+ entry and cellular functions.

Purpose of the Study:

  • To investigate the role of Orai1 channels in regulating neuronal excitability and seizures.
  • To determine if Orai1 deletion in the brain affects seizure severity induced by chemoconvulsants.
  • To elucidate the specific contribution of Orai1 in GABAergic neurons to seizure activity.

Main Methods:

  • Utilized brain-specific Orai1 knockout (KO) mice and conditional KO mice lacking Orai1 in GABAergic neurons.
  • Administered chemoconvulsants kainic acid (KA) and pilocarpine to induce seizures.
  • Performed electrophysiological recordings in hippocampal slices to assess neuronal activity and synaptic currents.

Main Results:

  • Orai1 knockout mice exhibited significantly stronger seizures and increased mortality following KA and pilocarpine administration.
  • Deletion of Orai1 in inhibitory neurons abolished chemoconvulsant-induced excitation of GABAergic neurons in the hippocampus.
  • Orai1 deletion abrogated the increase in spontaneous inhibitory postsynaptic currents (sIPSCs) in CA1 pyramidal neurons, indicating impaired inhibitory function.

Conclusions:

  • Orai1 channels are essential regulators of inhibitory interneuron excitability in the hippocampus.
  • Loss of Orai1 function disrupts the excitatory/inhibitory balance, exacerbating seizures.
  • Orai1 channels represent a novel molecular target for understanding and potentially treating temporal lobe epilepsy.

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
685
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.5K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
495
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.0K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
7.8K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
962